e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
925.11
+21.12 (+2.34%)
Streaming Delayed Price
Updated: 11:44 AM EDT, Apr 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,397,438
Open
917.80
Bid (Size)
924.73 (80)
Ask (Size)
925.47 (80)
Prev. Close
903.99
Today's Range
917.80 - 929.99
52wk Range
623.78 - 1,133.95
Shares Outstanding
956,580,893
Dividend Yield
0.75%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Ways to Invest in the Growing GLP-1 Weight Loss Market
↗
Today 11:20 EDT
Via
MarketBeat
Eli Lilly's Pill Lags Novo Nordisk's In First Week. Why Stock Rallied.
↗
Today 10:04 EDT
Eli Lilly's oral weight-loss drug, Foundayo, nabbed 1,390 prescriptions in its first week on the market, analysts said Friday.
Via
Investor's Business Daily
Performance
YTD
-14.4%
-14.4%
1 Month
-0.6%
-0.6%
3 Month
-10.4%
-10.4%
6 Month
+12.9%
+12.9%
1 Year
+25.9%
+25.9%
More News
Read More
Is Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026?
↗
Today 5:30 EDT
Via
The Motley Fool
3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist
↗
April 16, 2026
Via
The Motley Fool
Should You Forget CVS Health and Invest in a Purer Healthcare Play?
↗
April 16, 2026
Via
The Motley Fool
Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson
↗
April 16, 2026
Via
Benzinga
Is This $6.3 Billion Deal a Game Changer for Eli Lilly?
↗
April 16, 2026
Via
The Motley Fool
Eli Lilly's New Oral Weight Loss Drug Clears Cardiovascular Bar
↗
April 16, 2026
Via
Benzinga
Prediction: This 1 Thing Could Cement Eli Lilly's Leadership in the Billion-Dollar Weight Loss Drug Market
↗
April 16, 2026
Via
The Motley Fool
The $1 Trillion Race: Why Eli Lilly Is Leaving Novo Nordisk in the Dust
↗
April 15, 2026
Via
The Motley Fool
Worried About a Stock Market Crash? These 3 Stocks Beat the S&P 500 by Wide Margins When It Nosedived in 2022, and They Could Do It Again
↗
April 15, 2026
Via
The Motley Fool
Topics
Economy
Stocks
Revolution Medicines (RVMD): The New Titan of the RAS Pathway (2026 Research Feature)
April 15, 2026
Via
Finterra
Topics
Initial Public Offering
Could AbbVie Crash Lilly's Weight‑Loss Party?
↗
April 14, 2026
Via
The Motley Fool
Amazon (AMZN) Stock Is Up, What You Need To Know
April 14, 2026
Via
StockStory
Topics
Artificial Intelligence
The RAS Revolution: A Deep Dive into Revolution Medicines’ Path to Dominance (2026 Report)
April 14, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
$30 Billion Per Year US Heart Failure Market Presents Huge Opportunity for Promising Drugs Advancing with Positive Trial Results for Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)
April 13, 2026
Via
Get News
Topics
Intellectual Property
After Obtaining Approval for Its Weight Loss Pill, Is It Off to the Races for Eli Lilly Stock?
↗
April 13, 2026
Via
The Motley Fool
The Radiopharmaceutical Renaissance: A Deep Dive into Telix Pharmaceuticals (TLX)
April 13, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
The Science of Scale: An In-Depth Look at Regeneron Pharmaceuticals (REGN) in 2026
April 13, 2026
Via
Finterra
Topics
Earnings
Economy
Intellectual Property
Eli Lilly's Jaypirca Builds Case With Fourth Positive Phase 3 Trial In Blood Cancer Patients
↗
April 13, 2026
Via
Benzinga
Eli Lilly & Co (NYSE:LLY) Presents a Prime Case for Affordable Growth Investing
↗
April 13, 2026
Via
Chartmill
3 Mid-Cap Stocks Walking a Fine Line
April 13, 2026
Via
StockStory
1 Profitable Stock to Own for Decades and 2 That Underwhelm
April 13, 2026
Via
StockStory
The Post-Ozempic Economy? 2 Industries Bracing for a Slimmer, Less Hungry America
↗
April 12, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Eli Lilly Isn't Replacing Zepbound -- It's Building an Obesity Empire
↗
April 11, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 925.11
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 04/17/26 11:44 AM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 884.94B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 885B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert